Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum

scientific article

Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3121/CMR.4.1.1
P932PMC publication ID1435654
P698PubMed publication ID16595787
P5875ResearchGate publication ID7183658

P50authorFlorence Migot-NabiasQ37383641
Philippe DeloronQ56430125
P2093author name stringFlorence Migot-Nabias
Fousseyni S Touré
P2860cites workA malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin AQ24643787
A Plasmodium falciparum antigen that binds to host erythrocytes and merozoitesQ27230065
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparumQ33591313
Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodiesQ33761565
Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin AQ34002398
Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.Q34002481
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malariaQ34003525
Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasionQ35162176
Host age as a determinant of naturally acquired immunity to Plasmodium falciparumQ35846186
Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibitionQ36254695
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunityQ36943252
Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole bloodQ37235685
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.Q37331646
Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acidsQ39515040
Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclassQ39823427
Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodiesQ39830868
Biological activities of immunoglobulins of different classes and subclasses.Q39949391
Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa.Q40635057
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New GuineaQ40694087
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.Q40734085
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsQ40920376
Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum.Q41460430
Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasionQ42129581
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytesQ42938913
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated formQ43690388
Aspects of the molecular structure of IgG subclasses.Q43972062
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infectionQ44147641
Relationships between maternal malaria and malarial immune responses in mothers and neonatesQ44198135
Sequence conservation of a functional domain of erythrocyte binding antigen 175 in Plasmodium falciparumQ44638315
Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa).Q44710649
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infectionsQ46184700
Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malariaQ46227346
Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children.Q46573615
A hypothesis about the chronicity of malaria infectionQ46833996
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.Q47830190
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimenQ47874795
Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.Q47875788
Two alleles of the 175-kilodalton Plasmodium falciparum erythrocyte binding antigenQ48112376
EBA-175: an erythrocyte-binding ligand of Plasmodium falciparum.Q53872636
P433issue1
P921main subjectantibodyQ79460
Plasmodium falciparumQ311383
P304page(s)1-6
P577publication date2006-03-01
P1433published inClinical Medicine & ResearchQ15757811
P1476titleAnalysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum
P478volume4